Calcimedica, Inc.2025财年第三财季实现净利润-7.80百万美元，同比减少38.79%

市场透视2025-11-17

11月17日，Calcimedica, Inc.（CALC.US）公布财报，公告显示公司2025财年第三财季净利润为-7.80百万美元，同比减少38.79%；其中营业收入为0.00美元，每股基本收益为-0.52美元。从资产负债表来看，Calcimedica, Inc.（CALC.US）总负债15.18百万美元，其中短期债务0.00美元，资产负债比为0.99，流动比率为4.04。机构评级：截至...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2584469646?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-17 00:03","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2584469646","market":"us","top_or_hot":-1,"title":"Calcimedica, Inc.2025财年第三财季实现净利润-7.80百万美元，同比减少38.79%","media":"市场透视","content":"<div>\n<p>11月17日，Calcimedica, Inc.（CALC.US）公布财报，公告显示公司2025财年第三财季净利润为-7.80百万美元，同比减少38.79%；其中营业收入为0.00美元，每股基本收益为-0.52美元。从资产负债表来看，Calcimedica, Inc.（CALC.US）总负债15.18百万美元，其中短期债务0.00美元，资产负债比为0.99，流动比率为4.04。机构评级：截至...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111700034295081820&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Calcimedica, Inc.2025财年第三财季实现净利润-7.80百万美元，同比减少38.79%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCalcimedica, Inc.2025财年第三财季实现净利润-7.80百万美元，同比减少38.79%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-17 00:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111700034295081820&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月17日，Calcimedica, Inc.（CALC.US）公布财报，公告显示公司2025财年第三财季净利润为-7.80百万美元，同比减少38.79%；其中营业收入为0.00美元，每股基本收益为-0.52美元。从资产负债表来看，Calcimedica, Inc.（CALC.US）总负债15.18百万美元，其中短期债务0.00美元，资产负债比为0.99，流动比率为4.04。机构评级：截至...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111700034295081820&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CALC","symbol_name":"CALCIMEDICA","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111700034295081820&s=b","article_id":"2584469646","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111700034295081820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2584469646","pubTimestamp":1763308982,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月17日，Calcimedica, Inc.公布财报，公告显示公司2025财年第三财季净利润为-7.80百万美元，同比减少38.79%；其中营业收入为0.00美元，每股基本收益为-0.52美元。从资产负债表来看，Calcimedica, Inc.总负债15.18百万美元，其中短期债务0.00美元，资产负债比为0.99，流动比率为4.04。机构评级：截至2025年11月17日，当前有4家机构对Calcimedica, Inc.目标价做出预测，其中目标均价为16.25美元，其中最低目标价为14.00美元，最高目标价为20.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"CALC":"CALCIMEDICA"},"translate_title":"Calcimedica, Inc. achieved net profit of-7.80 million US dollars in the third fiscal quarter of fiscal year 2025, a year-on-year decrease of 38.79%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CALC":1.5},"content_text":"11月17日，Calcimedica, Inc.（CALC.US）公布财报，公告显示公司2025财年第三财季净利润为-7.80百万美元，同比减少38.79%；其中营业收入为0.00美元，每股基本收益为-0.52美元。从资产负债表来看，Calcimedica, Inc.（CALC.US）总负债15.18百万美元，其中短期债务0.00美元，资产负债比为0.99，流动比率为4.04。机构评级：截至2025年11月17日，当前有4家机构对Calcimedica, Inc.目标价做出预测，其中目标均价为16.25美元，其中最低目标价为14.00美元，最高目标价为20.00美元。公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。其候选产品作用于钙释放活化钙 （CRAC） 通道，将构成一类新药。其候选产品是 Auxora，一种有效的选择性静脉内配方小分子 CRAC 通道抑制剂，含有活性化合物 zegocractin（以前称为 CM4620），在动物模型中，可减少急性上皮和/或内皮细胞损伤和器官炎症，如胰腺、肺和肾脏。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584469646","isCrawlerRequest":true}